Isn’t that Her-vaxx in combo with Key-vaxx? I believed that’s what achieved the 90% inhibition.
Imugene are just focusing on a partnership which is brilliant. If the market is after a PD-1 they went out and snatched some up.
If the potential for a partnership is more likely to eventuate with the PD-1 than they should move Her-vaxx to the background.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.045(10.6%) |
Mkt cap ! $83.46M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 38.0¢ | 34.5¢ | $1.196M | 3.248M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2058 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 53026 | 3 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |